Human prothrombin complex (Sinopharm Shanghai Plasma)

人凝血酶原复合物（国药上海血液）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex (Sinopharm Shanghai Plasma)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeB02BD01
Related LinksN/A